Showing results (81-90 of 156) with videos related to

Sort By:
Pageof 16
The Journal of Clinical Endocrinology and Metabolism|December 5, 2013
Serum Dickkopf 1 levels in sclerostin deficiencyA H van Lierop, M J C Moester, N A T Hamdy, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 14, 2021
Denosumab for the treatment of primary pediatric osteoporosisA D Anastasilakis, P Makras, A Doulgeraki, et al.
Calcified Tissue International|May 18, 2010
Sclerostin: current knowledge and future perspectivesM J C Moester, S E Papapoulos, C W G M Löwik, et al.
The Journal of Investigative Dermatology|March 1, 1995
Differential regulation of plasminogen activation in normal keratinocytes and SCC-4 cells by fibroblastsI L Boxman, P H Quax, C W Löwik, et al.
Clinical Science (London, England : 1979)|April 1, 1982
The effect of renal function on changes in circulating concentrations of 1,25-dihydroxycholecalciferol after an oral doseS E Papapoulos, T L Clemens, L M Sandler, et al.
British Medical Journal (Clinical Research Ed.)|November 21, 1987
Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD)H I Harinck, S E Papapoulos, H J Blanksma, et al.
Bone|May 16, 2009
Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosisP Makras, N A T Hamdy, A H Zwinderman, et al.
Annals of the Rheumatic Diseases|September 14, 2002
Interleukin 17 synergises with tumour necrosis factor alpha to induce cartilage destruction in vitroR L Van Bezooijen, L Van Der Wee-Pals, S E Papapoulos, et al.
Endocrinology|May 10, 2000
Expression of vascular endothelial growth factors and their receptors during osteoblast differentiationM M Deckers, M Karperien, C van der Bent, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1987
Serum osteocalcin in Paget's disease of bone: basal concentrations and response to bisphosphonate treatmentS E Papapoulos, M Frolich, A H Mudde, et al.
Pageof 16